Cardiac Perfusion Solution Recalled for Sterility Assurance Issues
Central Admixture Pharmacy Services is recalling Modified del Nido Microplegia syringes after an FDA inspection raised concerns about their sterility. Approximately 690 syringes distributed nationwide may be affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for suspected sterility failure in a product intended for surgical use. No illnesses or injuries have been reported; the hazard remains theoretical, placing this in the High category per the severity rubric.
Plain-English summary
Modified del Nido Microplegia, a cardiac perfusion solution used in heart surgery, is being recalled by Central Admixture Pharmacy Services, Inc. The recall was initiated after an FDA inspection questioned the sterility of the product, which is meant to be sterile for surgical use.
Approximately 690 syringes were distributed nationwide in 40 mL units. The affected product (NDC 71285-0219-1) includes the following lot numbers and expiration dates: Lot 37-893821 (Exp 04/28/2023); 37-894813 and 37-894815 (Exp 04/30/2023); 37-895489 and 37-895490 (Exp 05/05/2023); 37-897810 and 37-897811 (Exp 05/13/2023); and 37-899585 (Exp 05/20/2023).
This recall affects healthcare facilities and providers nationwide. Anyone with affected syringes should verify inventory against the lot numbers and expiration dates listed above and refrain from using affected units.
The recalled product
- Product
- Modified del Nido Microplegia, packaged in 40 mL per syringe, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0219-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Hazard
- contamination-risk
- sterility-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot # 37-893821
- Exp 04/28/2023
- 37-894813
- 37-894815
- Exp 04/30/2023
- 37-895489
- 37-895490
- Exp 05/05/2023
- 37-897810
- 37-897811
- Exp 05/13/2023
- 37-899585
- Exp 05/20/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27